CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 980542593
- Phone
- (877) 237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-08 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-08 | SIMPSON TODD E Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-06-08 | PALEKAR ROHAN Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-06-08 | Noonberg Sarah B. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-06-08 | Lavelle Erin Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-06-08 | Babler Martin Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-04-03 | Patel Priti Former Chief Medical Officer | Sale | −3,769 | $0.69 | $3K | 37,313 |
| 2023-03-31 | Patel Priti Former Chief Medical Officer | Option exercise | +10,000 | 41,082 | ||
| 2023-03-31 | Patel Priti Former Chief Medical Officer | Option exercise · Restricted Stock Units | −10,000 | 0 | ||
| 2023-02-02 | Smith Sean Michael Principal Accounting Officer | Sale | −3,316 | $0.60 | $2K | 15,960 |
| 2023-02-02 | Patel Priti Chief Medical Officer | Sale | −14,380 | $0.60 | $9K | 31,082 |
| 2023-02-01 | Smith Sean Michael Principal Accounting Officer | Option exercise | +12,500 | 19,276 | ||
| 2023-02-01 | Smith Sean Michael Principal Accounting Officer | Option exercise · Restricted Stock Units | −12,500 | 12,500 | ||
| 2023-02-01 | Patel Priti Chief Medical Officer | Option exercise | +35,000 | 45,462 | ||
| 2023-02-01 | Patel Priti Chief Medical Officer | Option exercise · Restricted Stock Units | −35,000 | 35,000 | ||
| 2022-08-10 | Smith Sean Michael Principal Accounting Officer | Option exercise | +5,000 | 8,431 | ||
| 2022-08-10 | Smith Sean Michael Principal Accounting Officer | Sale | −1,655 | $0.99 | $2K | 6,776 |
| 2022-08-10 | Smith Sean Michael Principal Accounting Officer | Option exercise · Restricted Stock Units | −5,000 | 5,000 | ||
| 2022-08-02 | Walkey Carl Senior Vice President | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-08-02 | Smith Sean Michael Principal Accounting Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 |
Page 6 of 8 · 158 trades